Origin Materials, Inc. ORGN
We take great care to ensure that the data presented and summarized in this overview for Origin Materials, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ORGN
View all-
Vanguard Group Inc Valley Forge, PA5.55MShares$2.67 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$1.19 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.71MShares$823,0600.0% of portfolio
-
Apollo Management Holdings, L.P. New York, NY1.08MShares$516,6390.01% of portfolio
-
Cresset Asset Management, LLC Chicago, IL973KShares$466,9660.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA814KShares$390,5700.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL706KShares$338,7230.0% of portfolio
-
Jacobs Levy Equity Management, Inc Florham Park, NJ623KShares$299,2600.0% of portfolio
-
State Street Corp Boston, MA505KShares$242,5410.0% of portfolio
-
Royal Bank Of Canada Toronto, A6358KShares$171,9140.0% of portfolio
Latest Institutional Activity in ORGN
Top Purchases
Top Sells
About ORGN
Micromidas, Inc., doing business as Origin Materials, produces and commercializes plant-based PET plastic. It develops a platform for turning the carbon found in biomass into useful materials, while capturing carbon in the process. The company serves tire filler, carbon black, agriculture, and activated carbon markets. Micromidas, Inc. has a strategic alliance with Palantir Technologies Inc. The company was incorporated in 2008 and is based in West Sacramento, California with a facility in Sarnia, Canada.
Insider Transactions at ORGN
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2025
|
John Bissell CEO and Director |
SELL
Bona fide gift
|
Direct |
200,000
-8.92%
|
-
|
|
Nov 03
2025
|
Matthew T Plavan CFO and COO |
SELL
Open market or private sale
|
Direct |
150,000
-9.93%
|
$0
$0.55 P/Share
|
|
Sep 30
2025
|
Craig A Rogerson |
BUY
Grant, award, or other acquisition
|
Direct |
31,334
+5.61%
|
$0
$0.52 P/Share
|
|
Sep 30
2025
|
R Tony Tripeny |
BUY
Grant, award, or other acquisition
|
Direct |
24,103
+3.43%
|
$0
$0.52 P/Share
|
|
Sep 30
2025
|
John Hickox |
BUY
Grant, award, or other acquisition
|
Direct |
36,155
+4.14%
|
$0
$0.52 P/Share
|
|
Aug 21
2025
|
Joshua C. Lee General Counsel |
SELL
Open market or private sale
|
Direct |
3,860
-0.56%
|
$0
$0.56 P/Share
|
|
Jun 30
2025
|
R Tony Tripeny |
BUY
Grant, award, or other acquisition
|
Direct |
25,879
+3.81%
|
$0
$0.48 P/Share
|
|
Jun 30
2025
|
Craig A Rogerson |
BUY
Grant, award, or other acquisition
|
Direct |
33,643
+6.35%
|
$0
$0.48 P/Share
|
|
Jun 30
2025
|
John Hickox |
BUY
Grant, award, or other acquisition
|
Direct |
38,819
+4.63%
|
$0
$0.48 P/Share
|
|
Jun 11
2025
|
John Bissell CEO and Director |
BUY
Exercise of conversion of derivative security
|
Direct |
137,571
+5.78%
|
$0
$0.37 P/Share
|
|
May 06
2025
|
William J. Harvey |
BUY
Grant, award, or other acquisition
|
Direct |
172,894
+33.48%
|
-
|
|
May 06
2025
|
Craig A Rogerson |
BUY
Grant, award, or other acquisition
|
Direct |
172,894
+27.21%
|
-
|
|
May 06
2025
|
John Hickox |
BUY
Grant, award, or other acquisition
|
Direct |
172,894
+18.51%
|
-
|
|
May 06
2025
|
James C. Stephanou |
BUY
Grant, award, or other acquisition
|
Direct |
172,894
+32.89%
|
-
|
|
May 06
2025
|
Kathleen B Fish |
BUY
Grant, award, or other acquisition
|
Direct |
172,894
+27.71%
|
-
|
|
May 06
2025
|
R Tony Tripeny |
BUY
Grant, award, or other acquisition
|
Direct |
272,642
+30.28%
|
-
|
|
Mar 31
2025
|
Craig A Rogerson |
BUY
Grant, award, or other acquisition
|
Direct |
24,487
+7.8%
|
$0
$0.66 P/Share
|
|
Mar 31
2025
|
John Hickox |
BUY
Grant, award, or other acquisition
|
Direct |
28,254
+4.58%
|
$0
$0.66 P/Share
|
|
Mar 31
2025
|
R Tony Tripeny |
BUY
Grant, award, or other acquisition
|
Direct |
18,836
+5.04%
|
$0
$0.66 P/Share
|
|
Mar 05
2025
|
Matthew T Plavan CFO and COO |
SELL
Open market or private sale
|
Direct |
9,725
-0.64%
|
$0
$0.86 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 2.66M shares |
|---|---|
| Exercise of conversion of derivative security | 138K shares |
| Bona fide gift | 200K shares |
|---|---|
| Open market or private sale | 384K shares |